Candriam S.C.A. Pacific Biosciences Of California, Inc. Transaction History

Candriam S.C.A.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$19.26 - $30.08 $5.4 Million - $8.44 Million	-280,431 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$22.3 - $36.02 $6.25 Million - $10.1 Million	280,431 New	280,431 $9.81 Million
Q2 2020 Jul 23, 2020	SELL	$2.65 - $4.03 $1.09 Million - $1.66 Million	-411,991 Closed	0 $0
Q4 2019 Jan 21, 2020	BUY	$4.6 - $5.57 $370,925 - $449,142	80,636 Added 24.34%	411,991 $2,000
Q3 2019 Oct 21, 2019	SELL	$4.99 - $6.16 $9,980 - $12,320	-2,000 Reduced 0.6%	331,355 $2,000
Q2 2019 Aug 01, 2019	BUY	$5.92 - $7.41 $11,840 - $14,820	2,000 Added 0.6%	333,355 $3.89 Million
Q1 2019 May 02, 2019	BUY	$6.8 - $7.4 $299,200 - $325,600	44,000 Added 15.31%	331,355 $2.4 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $1.15 Million - $2.25 Million	287,355 New	287,355 $2.13 Million

252

227M

656K

939K

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $418M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.